SUBSCRIBE
SUBSCRIBE
News   Business

Lonza CEO Quits As Profit Tumbles, Shares Drop

October 19, 2005 | 
1 min read
Lonza (LONN.VX: Quote, Profile, Research) Chief Executive Markus Gemuend quit on Tuesday as the specialty chemicals maker posted a dire 59 percent drop in 2003 profit, hit by oversupply in the biotechnology market.
People
Lonza
MORE ON THIS TOPIC
FDA
Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay
May 13, 2026
 · 
1 min read
 · 
Heather McKenzie
Large hand making pressure over group of small, silhouetted figures. Oppressions, manipulation. Contemporary art collage. Photocopy effect. Concept of world crisis, business, economy, control
FDA
After ‘most damaging period in FDA history,’ Makary will be hard to replace
May 13, 2026
 · 
3 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
BioMarin trims Amicus headcount after acquisition
May 13, 2026
 · 
51 min read
 · 
BioSpace Editorial Staff
Inflation Bubble and the Financial. Crisis economic recession. Businessman inflating dollar sign balloon with tire pump. illustration
Venture capital
AI-fueled Isomorphic bags $2.1B, the second largest biotech round ever
May 13, 2026
 · 
2 min read
 · 
Tristan Manalac